SENS-AI
BTI AGM Notice Neutral

BRITISH AMERICAN TOBACCO PLC - Results of Voting at the 2026 Annual General Meeting

British American Tobacco p.l.c.
Full analysis

What this filing means

British American Tobacco shareholders overwhelmingly approved all 19 AGM resolutions, confirming routine governance continuity and maintaining capital allocation flexibility.

The company held its annual meeting where shareholders voted to approve all proposed rules, board members, and plans. This is a standard yearly event that shows investors are generally supportive of management.

Bull case

  • All 19 resolutions were passed by overwhelming majorities, demonstrating strong shareholder support for management and the Board.
  • The renewal of authority to make market purchases of ordinary shares (99.82% approval) ensures ongoing flexibility for capital allocation and buybacks.
  • Approval of the Sharesave Scheme extension (99.86%) reinforces employee alignment structures.

Bear case

  • Resolution 15 (authority to allot shares) saw a minor but notable 6.12% dissent, indicating slight caution around potential future dilution.
  • Resolution 17 (disapplying pre-emption rights) faced 4.76% opposition from shareholders wary of non-pre-emptive share issuance.
  • The ongoing board transitions are occurring against a backdrop of technical weakness, with the stock trading below both its 50-day and 200-day moving averages.
View original SENS announcement

AI-generated summary by SENS-AI, based on the original JSE SENS filing.

SENS-AI conclusion

British American Tobacco announced the passage of all 19 resolutions at its 2026 Annual General Meeting, including the renewal of share repurchase authority and the pre-announced appointment of Karen Guerra as Senior Independent Director. The overwhelming majority votes, despite minor single-digit dissent on share allotment and pre-emption rights, confirm broad shareholder alignment with current management. This is a routine governance completion, not a catalyst that alters the underlying valuation or fundamental earnings outlook. Investor Takeaway: The AGM results represent a procedural conclusion of the governance cycle with no surprises, leaving the core investment thesis unchanged. Rating Context: This is a technical/administrative event with no direct equity impact.

Routine filing. No equity signal. No portfolio action required.

Decision framework

Current stance: Filing Neutral

Key drivers

  • All 19 resolutions were passed by overwhelming majorities, demonstrating strong shareholder support for management and the Board.
  • The renewal of authority to make market purchases of ordinary shares (99.82% approval) ensures ongoing flexibility for capital allocation and buybacks.
  • Approval of the Sharesave Scheme extension (99.86%) reinforces employee alignment structures.

Key risks

  • Resolution 15 (authority to allot shares) saw a minor but notable 6.12% dissent, indicating slight caution around potential future dilution.
  • Resolution 17 (disapplying pre-emption rights) faced 4.76% opposition from shareholders wary of non-pre-emptive share issuance.
  • The ongoing board transitions are occurring against a backdrop of technical weakness, with the stock trading below both its 50-day and 200-day moving averages.

What would change the view

  • Guidance and cash-flow quality both improve materially from current baseline.
  • Subsequent filings remove current uncertainty and confirm durable execution.
  • Market structure/positioning shifts enough to support a directional thesis.

Evidence from the filing

  • Shareholders demonstrated overwhelming support for management, with all 19 resolutions passed, including the re-election of the Board and the approval of the 2025 Remuneration Report.

    “All resolutions were passed at the Company's AGM today with the requisite majority of votes.”

  • The renewal of the authority for the Company to make market purchases of ordinary shares provides ongoing flexibility for capital allocation and potential share buybacks.

    “18. Authority for the Company to make market purchases of ordinary shares 1,648,013,864 99.82% 2,958,547 0.18% 1,747,982 1,650,972,411 76.02%”

  • The extension of the Sharesave Scheme, approved with 99.86% of votes, reinforces the company's commitment to employee alignment and long-term incentive structures.

    “16. Extension of the British American Tobacco Sharesave Scheme 1,648,586,831 99.86% 2,336,841 0.14% 1,796,721 1,650,923,672 76.01%”

  • Significant shareholder dissent is evident in the renewal of the Directors' authority to allot shares (Resolution 15), which saw 6.12% of votes cast against the proposal, indicating investor concern regarding potential future dilution.

    “15. Renewal of Directors' authority to allot shares 1,550,136,310 93.88% 101,135,636 6.12%”

  • The renewal of authority to disapply pre-emption rights (Resolution 17) faced 4.76% opposition, suggesting a segment of the shareholder base remains wary of management's ability to issue shares without offering existing holders the right of first refusal.

    “17. Renewal of Directors' authority to disapply pre-emption rights 1,572,347,237 95.24% 78,504,052 4.76%”

  • The company's governance structure is undergoing a transition with the departure of Holly Keller Koeppel and the appointment of Karen Guerra as Senior Independent Director.

    “Holly Keller Koeppel stepped down from the Board as Non-Executive Directors at the conclusion of the Meeting and is succeeded by Karen Guerra as Senior Independent Director.”
Category
AGM Notice
Published
Apr 15, 2026

More on British American Tobacco p.l.c.

British American Tobacco p.l.c. (BTI) share price All British American Tobacco p.l.c. SENS announcements

Related filings